- Home
- DM vs PDSB Comparison
DM vs PDSB Comparison
Compare DM & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DM
- PDSB
- Stock Information
- Founded
- DM 2015
- PDSB 2005
- Country
- DM United States
- PDSB United States
- Employees
- DM N/A
- PDSB N/A
- Industry
- DM Industrial Machinery/Components
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- DM Technology
- PDSB Health Care
- Exchange
- DM Nasdaq
- PDSB Nasdaq
- Market Cap
- DM 101.0M
- PDSB 84.2M
- IPO Year
- DM N/A
- PDSB N/A
- Fundamental
- Price
- DM $2.18
- PDSB $1.68
- Analyst Decision
- DM Hold
- PDSB Strong Buy
- Analyst Count
- DM 1
- PDSB 3
- Target Price
- DM $5.50
- PDSB $14.00
- AVG Volume (30 Days)
- DM 359.0K
- PDSB 292.6K
- Earning Date
- DM 03-14-2025
- PDSB 11-14-2024
- Dividend Yield
- DM N/A
- PDSB N/A
- EPS Growth
- DM N/A
- PDSB N/A
- EPS
- DM N/A
- PDSB N/A
- Revenue
- DM $168,283,000.00
- PDSB N/A
- Revenue This Year
- DM N/A
- PDSB N/A
- Revenue Next Year
- DM $6.25
- PDSB N/A
- P/E Ratio
- DM N/A
- PDSB N/A
- Revenue Growth
- DM N/A
- PDSB N/A
- 52 Week Low
- DM $2.16
- PDSB $1.30
- 52 Week High
- DM $11.80
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- DM 29.47
- PDSB 48.47
- Support Level
- DM $2.37
- PDSB $1.37
- Resistance Level
- DM $2.50
- PDSB $1.50
- Average True Range (ATR)
- DM 0.23
- PDSB 0.14
- MACD
- DM 0.01
- PDSB 0.03
- Stochastic Oscillator
- DM 2.04
- PDSB 71.59
About DM Desktop Metal Inc.
Desktop Metal Inc manufactures 3D printing to make metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers. 3D metal printing helps in the design and development of automotive parts, consumer goods, manufacture of industrial equipment, and design of mechanical systems. The company ships its product to markets in the Americas, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It derives maximum revenue from Americas.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.